Delivery Order SPE2DB22D3016-SPE2DB24FBAQ5
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product XCOPRI 50 MG TABLET 30S to the U.S. Department of Defense (DoD). The $2,096.70 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical through a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA. The contract, which has a completion date of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.24 firm fixed-price delivery order is for the supply of XCOPRI 150 MG tablets to support military healthcare programs. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XCOPRI 200 MG TABLET 30S to the Defense Logistics Agency (DLA). The award, valued at $2,444.08, is a Firm Fixed Price Delivery Order contract with a completion date of May 1, 2023. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,433.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of XCOPRI 150 MG TABLET 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for providing pharmaceutical products and medical...
The U.S. government has awarded a Delivery Order contract worth $5,894.80 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distribution company. The $2,415.19 Firm Fixed Price Delivery Order is for the supply of XCOPRI 100 MG TABLET 30S, a prescription medication. The contract does not have a set-aside designation and has a period of performance through June 27, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,702.63, is a Firm Fixed Price Delivery Order for the pharmaceutical product XCOPRI 100 MG TABLET 30S. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of XCOPRI 50 MG TABLET 30S to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,296.61, has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,134.91 firm fixed-price contract is for the delivery of 4567021601 XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,082.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of June 29, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...